Ugochi Ogu is an Oncology physician affiliated with University of Tennessee Health Science Center. OpenAlex indexes 45 publications with 212 citations (h-index 7); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
880 Madison Ave
Memphis, TN 381033409
Telephone
901-545-8535Provider last certified this registry record 18 Mar 2020.
Clinical trials
- The Predictive Capacity of Machine Learning Models for Progressive Kidney Disease in Individuals With Sickle Cell Anemia
Sponsor: University of Tennessee
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20256 payments$17,083openpaymentsdata.cms.gov ↗
- PFIZER INC.Program year202511 payments$13,243openpaymentsdata.cms.gov ↗
- Agios Pharmaceuticals, Inc.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
50.2%Opioid Agonist50.2%Oxycodone Hcl67%Oxycodone-Acetaminophen20%Hydromorphone Hcl8%Methadone Hcl6%Part D<11 patientsRespiratory
16%Phenothiazine9.2%Promethazine Hcl100%Part D<11 patientsOpioid Agonist6.8%Hydrocodone-Acetaminophen100%Part D<11 patientsBlood & clotting
12.2%Selectin Blocker8.8%Adakveo100%Part D<11 patientsHemoglobin S Polymerization Inhibitor3.5%Oxbryta100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Csaba Kovesdy, MD
University of Tennessee Health Science Center
Samuel Dagogo-Jack, MD
University of Tennessee Health Science Center
Lucas Elijovich, MD
University of Tennessee Health Science Center
Carmine Zoccali
University of Tennessee Health Science Center
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”